Analyzing tumor RNA sequencing data from all checkmate patients showed that elevated expression of the six genes previously identified, which are associated with resistance to CD40L-CD40 signaling–induced noncanonical cytotoxicity, is linked to worse survival outcomes (Fig. 7F). The gene discussed is CD40LG; the disease is neoplasm.